We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.45B
AUM Growth
+$91.7M
Cap. Flow
-$34M
Cap. Flow %
-2.34%
Top 10 Hldgs %
38.91%
Holding
217
New
7
Increased
36
Reduced
127
Closed
14

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$2.91M
2
MDT icon
Medtronic
MDT
+$2.84M
3
PRGO icon
Perrigo
PRGO
+$2.61M
4
TER icon
Teradyne
TER
+$1.71M
5
TJX icon
TJX Companies
TJX
+$1.61M

Sector Composition

Rank Sector Weight
1 Technology 25.94%
2 Healthcare 25.6%
3 Industrials 15.08%
4 Consumer Discretionary 10.81%
5 Communication Services 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
26
Waste Management
WM
$90.5B
$21.2M 1.46%
129,739
+1,735
+1% +$266K
GOOG icon
27
Alphabet (Google) Class C
GOOG
$4.19T
$20.6M 1.42%
198,286
-8,733
-4% -$843K
ILMN icon
28
Illumina
ILMN
$29B
$20.3M 1.4%
89,884
-4,032
-4% -$825K
APH icon
29
Amphenol
APH
$209B
$20M 1.38%
489,202
-156
-0% -$6.16K
SYY icon
30
Sysco
SYY
$40.6B
$19.8M 1.36%
256,542
+14,212
+6% +$1.09M
UL icon
31
Unilever
UL
$133B
$19.2M 1.32%
328,147
-13,583
-4% -$772K
SBUX icon
32
Starbucks
SBUX
$124B
$16.6M 1.14%
159,739
-4,157
-3% -$433K
AMZN icon
33
Amazon
AMZN
$2.9T
$16.4M 1.13%
158,924
+952
+0.6% +$92K
JNJ icon
34
Johnson & Johnson
JNJ
$630B
$15.3M 1.05%
98,548
-2,827
-3% -$456K
HD icon
35
Home Depot
HD
$344B
$15M 1.03%
50,682
+903
+2% +$277K
MDT icon
36
Medtronic
MDT
$116B
$14.8M 1.02%
183,486
+34,819
+23% +$2.84M
TER icon
37
Teradyne
TER
$62.9B
$12.9M 0.89%
120,110
+16,721
+16% +$1.71M
NVS icon
38
Novartis
NVS
$290B
$12.2M 0.84%
133,051
-7,704
-5% -$673K
APTV icon
39
Aptiv
APTV
$10B
$11.5M 0.79%
102,917
+26,356
+34% +$2.91M
MKTX icon
40
MarketAxess Holdings
MKTX
$5.72B
$10.7M 0.73%
27,254
-406
-1% -$144K
IBM icon
41
IBM
IBM
$222B
$9.16M 0.63%
69,870
+11,632
+20% +$1.56M
AMD icon
42
Advanced Micro Devices
AMD
$787B
$8.6M 0.59%
87,787
-8,621
-9% -$702K
VEEV icon
43
Veeva Systems
VEEV
$39B
$8.31M 0.57%
45,217
-2,578
-5% -$440K
TMO icon
44
Thermo Fisher Scientific
TMO
$223B
$6.58M 0.45%
11,418
-264
-2% -$149K
ABBV icon
45
AbbVie
ABBV
$440B
$6.56M 0.45%
41,167
+263
+0.6% +$40.2K
ENPH icon
46
Enphase Energy
ENPH
$5.4B
$6.32M 0.43%
30,041
+605
+2% +$131K
COST icon
47
Costco
COST
$421B
$5.68M 0.39%
11,438
+337
+3% +$165K
V icon
48
Visa
V
$673B
$4.48M 0.31%
19,889
-396
-2% -$88.1K
MRK icon
49
Merck
MRK
$330B
$4.45M 0.31%
41,793
-1,061
-2% -$115K
PEP icon
50
PepsiCo
PEP
$189B
$4.44M 0.31%
24,336
-199
-0.8% -$34.8K

Similar funds

Reynders McVeigh Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Reynders McVeigh Capital Management held 217 positions worth $1.45B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Reynders McVeigh Capital Management's Q1 2023 filing shows 7 new, 36 increased, 127 reduced and 14 closed positions. Its largest new stake was Perrigo: 72,303 shares worth $2.59M. The largest sale was Apple, an estimated $3.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Reynders McVeigh Capital Management's largest Q1 2023 buy was Perrigo: 72,303 shares worth $2.59M.
  • Reynders McVeigh Capital Management added most to Aptiv in Q1 2023, an estimated $2.91M increase.
  • Reynders McVeigh Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $3.9M.
  • Reynders McVeigh Capital Management fully exited AstraZeneca in Q1 2023, selling an estimated $651K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 39% of its $1.45B portfolio in Q1 2023.
  • Reynders McVeigh Capital Management opened 7 new positions and closed 14 in Q1 2023.
  • Reynders McVeigh Capital Management's portfolio value rose 6.7% quarter-over-quarter to $1.45B.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2023, filed 3 May 2023.